期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Application of serum surface-enhanced laser desorption/ionization proteomic patterns in distinguishing lung cancer patients from healthy people 被引量:48
1
作者 YANGShuan-ying XIAOXue-yuan +6 位作者 ZHANGWang-gang SUNXiu-zhen ZHANGLi-juan ZHANGWei ZHOUBin CHENGuo-an HEDa-cheng 《Chinese Medical Journal》 SCIE CAS CSCD 2005年第12期1036-1039,共4页
Screening and early diagnosis of lung cancer relies mainly on chest X-ray, low-dose computed tomography, bronchoscopy, sputum cytology, and measurement of tumor markers such as carcinoembryonic antigen (CEA), cytokera... Screening and early diagnosis of lung cancer relies mainly on chest X-ray, low-dose computed tomography, bronchoscopy, sputum cytology, and measurement of tumor markers such as carcinoembryonic antigen (CEA), cytokeratin-19 fragments (Cyfra21-1), and neuron-specific enolase (NSE). However, all these methods lack adequate sensitivity and/or specificity. 1-3 Better methods are therefore urgently needed in screening and early diagnosis of lung cancer, and proteomic fingerprinting represents a promising approach. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS), an innovative proteomic technology, has overcome many of the limitations of two-dimensional electrophoresis (2D) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). 4,5 Recently, this technology has been successfully used to distinguish pancreatic, ovarian and prostate cancer patients from healthy control subjects. 5-7 The aim of the current study was to investigate the application of serum SELDI protein profiling in distinguishing lung cancer patients from healthy persons. 展开更多
关键词 lung cancer · proteinchip · biomarker · early diagnosis
原文传递
Discovery of lung squamous carcinoma biomarkers by profiling the plasma peptide with LC/MS/MS
2
作者 Yu Liu Xiao-Hong Xun +2 位作者 Jian-Ming Yi Yang Xiang Jie Hua 《Chinese Chemical Letters》 SCIE CAS CSCD 2017年第5期1093-1098,共6页
Biomarkers can be used for the screening and clinical diagnosis of cancer,and peptidomics approach has been proven successful in the research of biomarkers.To develop better peptidomic technologies for fast,accurate,a... Biomarkers can be used for the screening and clinical diagnosis of cancer,and peptidomics approach has been proven successful in the research of biomarkers.To develop better peptidomic technologies for fast,accurate,and reliable detection of peptides biomarkers for lung cancer,we have improved the procedures of blood collection to minimize the degradation of the blood proteins and optimize the extraction of peptidome peptides from plasma samples based on acetonitrile precipitation associated with size exclusion chromatography(SEC).Studies show that squamous cell carcinomas are found to express CAGEl,SPAT9 and TEX28 genes at significantly higher rates,and the results suggest that as tumors progress,the level of CAGEl,SPAT9 and TEX28 genes are likely to increase and lead to immunization.This suggests a potentially important therapeutic method for cancer testis-based cancer vaccines. 展开更多
关键词 lung cancer lung squamous carcinoma biomarkers cancer testis antigen Peptidomics
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部